![Zadik Hazan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Zadik Hazan
Directeur Technique/Scientifique/R&D chez Hy BioPharma, Inc.
Profil
Zadik Hazan currently works at Regenera Pharma Ltd., as Director & Chief Scientific Officer and Hy BioPharma, Inc., as Vice President-Research.
Postes actifs de Zadik Hazan
Sociétés | Poste | Début |
---|---|---|
Hy BioPharma, Inc.
![]() Hy BioPharma, Inc. Medical DistributorsDistribution Services Hy BioPharma, Inc. develops drug technology solutions. The company develops Hypericin for the treatment of cancer, autoimmune disorders, and inflammation. It was established in 2006 and is headquartered in Jamison, PA. | Directeur Technique/Scientifique/R&D | 22/04/2009 |
Regenera Pharma Ltd.
![]() Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Hy BioPharma, Inc.
![]() Hy BioPharma, Inc. Medical DistributorsDistribution Services Hy BioPharma, Inc. develops drug technology solutions. The company develops Hypericin for the treatment of cancer, autoimmune disorders, and inflammation. It was established in 2006 and is headquartered in Jamison, PA. | Distribution Services |
Regenera Pharma Ltd.
![]() Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Health Technology |